Serum Bioavailable, Rather Than Total, 25‐hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival

Ai‐Ping Fang, Jing‐An Long, Yao‐Jun Zhang, Zhao‐Yan Liu, Qi‐Jiong Li, Dao‐Ming Zhang, Yun Luo, Rong‐Huan Zhong, Zhong‐Guo Zhou, Yan‐Jun Xu, Xiao‐Jun Xu, Wen‐Hua Ling, Min‐Shan Chen, Hui‐Lian Zhu – 2 November 2019

Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma

Katherine S. Cools, Andrew M. Moon, Lauren M. B. Burke, Katrina A. McGinty, Paula D. Strassle, David A. Gerber – 2 November 2019 – Single hepatocellular carcinoma (HCC) tumors can be successfully eradicated with thermal ablation (TA). We assessed the validity of the Liver Imaging Reporting and Data System Treatment Response (LR‐TR) criteria with a retrospective analysis of a single‐center database of patients with small HCC tumors (<3 cm in diameter) who underwent both laparoscopic TA and liver transplantation (LT) from 2004 to 2018.

Frailty and the Burden of Concurrent and Incident Disability in Patients With Cirrhosis: A Prospective Cohort Study

Jennifer C. Lai, Jennifer L. Dodge, Charles E. McCulloch, Kenneth E. Covinsky, Jonathan P. Singer – 31 October 2019 – Frailty results from the chronic effects of malnutrition and muscle wasting in patients with cirrhosis. It is well‐established that frailty is strongly associated with mortality in this population. However, little is known of its relationship with physical disability, a critical patient‐centered outcome.

Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis

Jaswinder Singh Maras, Sukanta Das, Adil Bhat, Ashish Kumar Vyas, Gaurav Yadav, Sudrishti Chaudhary, Sukriti Sukriti, Abhishak C. Gupta, Chagan Bihari, Rakhi Mahiwall, Shiv Kumar Sarin – 30 October 2019 – Severe alcoholic hepatitis (SAH) has high mortality. Dysregulated lipid transport and metabolism in liver/macrophages contributes to disease pathophysiology. Paraoxonase/arylesterase 1 (PON1), a liver‐specific enzyme, inhibits oxidation of phospholipids and prevents lipid‐mediated oxidative damage.

Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox

Sanjaya K. Satapathy, Yu Jiang, Uchenna Agbim, Cen Wu, David E. Bernstein, Lewis W. Teperman, Satish K. Kedia, Guruprasad P. Aithal, Kalyan Ram Bhamidimarri, Ajay Duseja, Rakhi Maiwall, Benedict Maliakkal, Prasun Jalal, Keyur Patel, Puneet Puri, Ravi Ravinuthala, Vincent Wai‐Sun Wong, Manal F. Abdelmalek, Aijaz Ahmed, Paul J. Thuluvath, Ashwani K. Singal, for the Global NAFLD Consortium – 30 October 2019 – Morbid obesity is considered a relative contraindication for liver transplantation (LT).

Subscribe to